INVA Q3 2019 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$66M+6.6% YoY

Gross Profit

$66M100.0% margin

Operating Income

$61M92.5% margin

Net Income

$40M60.5% margin

EPS (Diluted)

$0.36

QoQ Revenue Growth

+2.6%

Cash Flow

Operating Cash Flow

$57M

Free Cash Flow

$57M

Stock-Based Comp.

$489,000

Balance Sheet

Total Assets

$676M

Total Liabilities

$392M

Stockholders' Equity

$267M

Cash & Equivalents

$173M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$66M	$62M	+6.6%
Gross Profit	$66M	$62M	+6.6%
Operating Income	$61M	$58M	+5.4%
Net Income	$40M	$47M	-15.5%